WO2009053713A3 - System for assisting in drug dose optimisation - Google Patents

System for assisting in drug dose optimisation Download PDF

Info

Publication number
WO2009053713A3
WO2009053713A3 PCT/GB2008/003618 GB2008003618W WO2009053713A3 WO 2009053713 A3 WO2009053713 A3 WO 2009053713A3 GB 2008003618 W GB2008003618 W GB 2008003618W WO 2009053713 A3 WO2009053713 A3 WO 2009053713A3
Authority
WO
WIPO (PCT)
Prior art keywords
patient
medication
assisting
dosage
data
Prior art date
Application number
PCT/GB2008/003618
Other languages
French (fr)
Other versions
WO2009053713A2 (en
Inventor
Lionel Tarassenko
David J Kerr
Annie Young
Original Assignee
T & Medical Ltd
Lionel Tarassenko
David J Kerr
Annie Young
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by T & Medical Ltd, Lionel Tarassenko, David J Kerr, Annie Young filed Critical T & Medical Ltd
Priority to JP2010530547A priority Critical patent/JP2011501311A/en
Priority to US12/734,332 priority patent/US20100312580A1/en
Priority to AU2008315720A priority patent/AU2008315720A1/en
Priority to EP08840912A priority patent/EP2215574A2/en
Publication of WO2009053713A2 publication Critical patent/WO2009053713A2/en
Publication of WO2009053713A3 publication Critical patent/WO2009053713A3/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

A system for assisting in dose optimisation for patients administering medication to themselves at home consists of a mobile telephone or PDA to which the patient is prompted to enter data indicative of their condition and also the dosage of medication they are taking. Such data is stored on the phone and transmitted to a remote server and is processed against predetermined criteria to decide whether the medication dose should be maintained or increased or decreased based on the patient's current condition. A message instructing the patient to maintain or adjust the dosage is displayed based on this determination. The data is made available both to the patient and clinicians by means of web pages provided by the remote server.
PCT/GB2008/003618 2007-10-26 2008-10-27 System for assisting in drug dose optimisation WO2009053713A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2010530547A JP2011501311A (en) 2007-10-26 2008-10-27 A system that supports drug dosage optimization
US12/734,332 US20100312580A1 (en) 2007-10-26 2008-10-27 System for assisting in drug dose optimisation
AU2008315720A AU2008315720A1 (en) 2007-10-26 2008-10-27 System for assisting in drug dose optimisation
EP08840912A EP2215574A2 (en) 2007-10-26 2008-10-27 System for assisting in drug dose optimisation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0721117.0A GB0721117D0 (en) 2007-10-26 2007-10-26 system for assisting in drug dose optimisaion
GB072117.0 2007-10-26

Publications (2)

Publication Number Publication Date
WO2009053713A2 WO2009053713A2 (en) 2009-04-30
WO2009053713A3 true WO2009053713A3 (en) 2009-07-30

Family

ID=38830065

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/003618 WO2009053713A2 (en) 2007-10-26 2008-10-27 System for assisting in drug dose optimisation

Country Status (6)

Country Link
US (1) US20100312580A1 (en)
EP (1) EP2215574A2 (en)
JP (1) JP2011501311A (en)
AU (1) AU2008315720A1 (en)
GB (1) GB0721117D0 (en)
WO (1) WO2009053713A2 (en)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10353856B2 (en) 2011-03-17 2019-07-16 Carefusion 303, Inc. Scalable communication system
US9427520B2 (en) 2005-02-11 2016-08-30 Carefusion 303, Inc. Management of pending medication orders
US11087873B2 (en) 2000-05-18 2021-08-10 Carefusion 303, Inc. Context-aware healthcare notification system
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
EP1920418A4 (en) 2005-09-01 2010-12-29 Proteus Biomedical Inc Implantable zero-wire communications system
CN105468895A (en) 2006-05-02 2016-04-06 普罗透斯数字保健公司 Patient customized therapeutic regimens
EP2087589B1 (en) 2006-10-17 2011-11-23 Proteus Biomedical, Inc. Low voltage oscillator for medical devices
SG175681A1 (en) 2006-10-25 2011-11-28 Proteus Biomedical Inc Controlled activation ingestible identifier
EP2069004A4 (en) 2006-11-20 2014-07-09 Proteus Digital Health Inc Active signal processing personal health signal receivers
ES2930588T3 (en) 2007-02-01 2022-12-19 Otsuka Pharma Co Ltd Ingestible Event Marker Systems
CA3000257C (en) 2007-02-14 2020-04-28 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
FI2192946T3 (en) 2007-09-25 2022-11-30 In-body device with virtual dipole signal amplification
DK2268261T3 (en) 2008-03-05 2017-08-28 Proteus Digital Health Inc Edible event markers with multi-mode communications and systems as well as methods for using them
SG195535A1 (en) 2008-07-08 2013-12-30 Proteus Digital Health Inc Ingestible event marker data framework
CN104382598A (en) 2008-08-13 2015-03-04 普罗透斯数字保健公司 Method of producing a recognizer
EP2349445A4 (en) 2008-11-13 2012-05-23 Proteus Biomedical Inc Ingestible therapy activator system and method
EP2358270A4 (en) 2008-12-11 2014-08-13 Proteus Digital Health Inc Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
TWI503101B (en) 2008-12-15 2015-10-11 Proteus Digital Health Inc Body-associated receiver and method
AU2010203737B2 (en) 2009-01-06 2016-09-15 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical dosages delivery system
JP2012514799A (en) 2009-01-06 2012-06-28 プロテウス バイオメディカル インコーポレイテッド Methods and systems for ingestion related biofeedback and individual pharmacotherapy
GB2480965B (en) 2009-03-25 2014-10-08 Proteus Digital Health Inc Probablistic pharmacokinetic and pharmacodynamic modeling
SG175388A1 (en) 2009-04-28 2011-12-29 Proteus Biomedical Inc Highly reliable ingestible event markers and methods for using the same
EP2432458A4 (en) 2009-05-12 2014-02-12 Proteus Digital Health Inc Ingestible event markers comprising an ingestible component
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
TWI517050B (en) 2009-11-04 2016-01-11 普羅托斯數位健康公司 System for supply chain management
UA109424C2 (en) 2009-12-02 2015-08-25 PHARMACEUTICAL PRODUCT, PHARMACEUTICAL TABLE WITH ELECTRONIC MARKER AND METHOD OF MANUFACTURING PHARMACEUTICAL TABLETS
SG182825A1 (en) 2010-02-01 2012-09-27 Proteus Biomedical Inc Data gathering system
AU2011237612B2 (en) 2010-04-07 2016-05-12 Otsuka Pharmaceutical Co., Ltd. Miniature ingestible device
TWI557672B (en) 2010-05-19 2016-11-11 波提亞斯數位康健公司 Computer system and computer-implemented method to track medication from manufacturer to a patient, apparatus and method for confirming delivery of medication to a patient, patient interface device
US9901563B2 (en) 2013-03-11 2018-02-27 Delmar Pharmaceuticals, Inc. Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
EP2642983A4 (en) 2010-11-22 2014-03-12 Proteus Digital Health Inc Ingestible device with pharmaceutical product
WO2012125425A2 (en) 2011-03-11 2012-09-20 Proteus Biomedical, Inc. Wearable personal body associated device with various physical configurations
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
KR101898964B1 (en) 2011-07-21 2018-09-14 프로테우스 디지털 헬스, 인코포레이티드 Mobile communication device, system, and method
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US20140353049A1 (en) * 2012-03-11 2014-12-04 Monique S. Vidal Digital Scale to Measure Human Weight and to Determine and Display Suitable Dosage of a Medicament
KR20150038038A (en) 2012-07-23 2015-04-08 프로테우스 디지털 헬스, 인코포레이티드 Techniques for manufacturing ingestible event markers comprising an ingestible component
JP5869736B2 (en) 2012-10-18 2016-02-24 プロテウス デジタル ヘルス， インコーポレイテッド Apparatus, system, and method for adaptively optimizing power dissipation and broadcast power in a power supply for a communication device
GB2507812A (en) * 2012-11-13 2014-05-14 Healthquest Solutions Ltd Monitoring medical activity of a patient
JP2016508529A (en) 2013-01-29 2016-03-22 プロテウス デジタル ヘルス， インコーポレイテッド Highly expandable polymer film and composition containing the same
US11182728B2 (en) 2013-01-30 2021-11-23 Carefusion 303, Inc. Medication workflow management
WO2014190200A1 (en) 2013-05-22 2014-11-27 Carefusion 303, Inc. Medication workflow management
BR112015019758B1 (en) * 2013-03-13 2022-07-05 Carefusion 303, Inc SYSTEM AND METHOD FOR USE WITH MEDICAL DEVICE TO REDUCE MEDICATION ERRORS AND MACHINE-READABLE STORAGE MEDIA
CN114267429A (en) 2013-03-13 2022-04-01 康尔福盛303公司 Predictive medication safety
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
WO2014151929A1 (en) 2013-03-15 2014-09-25 Proteus Digital Health, Inc. Personal authentication apparatus system and method
JP6511439B2 (en) 2013-06-04 2019-05-15 プロテウス デジタル ヘルス， インコーポレイテッド Systems, devices, and methods for data collection and outcome assessment
WO2014194410A1 (en) 2013-06-06 2014-12-11 Timeless Technologies (2007) Inc. Method and system for providing a treatment protocol
ITFI20130142A1 (en) * 2013-06-12 2014-12-13 Carlo Giuseppe Brianza APPARATUS FOR THE AUTOMATIC MANAGEMENT OF THE ASSUMPTION OF MEDICINAL PRODUCTS BY THE PATIENT.
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
CN105981017B (en) * 2013-09-20 2019-04-05 科赛普特治疗学股份有限公司 The system and method for distributing determining treatment using intervention and task
MX356850B (en) 2013-09-20 2018-06-15 Proteus Digital Health Inc Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping.
WO2015044722A1 (en) 2013-09-24 2015-04-02 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US20170185745A1 (en) * 2015-12-26 2017-06-29 Dan Wartski Technologies for customized drug provisioning
KR20210018961A (en) 2016-07-22 2021-02-18 프로테우스 디지털 헬스, 인코포레이티드 Electromagnetic sensing and detection of ingestible event markers
CA3041041A1 (en) 2016-10-26 2018-05-03 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers
CN110114833A (en) * 2016-12-23 2019-08-09 赛诺菲-安万特德国有限公司 Data management unit for supporting health control
CN110100285A (en) * 2016-12-23 2019-08-06 赛诺菲-安万特德国有限公司 Data Management Unit for supporting health to control
WO2020043734A1 (en) * 2018-08-28 2020-03-05 Novo Nordisk A/S Systems and methods for providing container based medication dose guidance to treat diabetes
JP6911087B2 (en) * 2019-10-16 2021-07-28 株式会社レゾナ Prescription drug management system, prescription drug management method and prescription drug management program
JP7422061B2 (en) 2019-12-11 2024-01-25 Ｅａファーマ株式会社 Constipation medication support program and constipation medication support method
JP2021111068A (en) * 2020-01-09 2021-08-02 富士通株式会社 Medicine blood concentration monitoring program, medicine blood concentration monitoring method, and medicine blood concentration monitoring system
US20220101971A1 (en) * 2020-09-28 2022-03-31 Optum, Inc. Predictive data analysis techniques for generating optimized drug delivery arrangements
JP2022068527A (en) * 2020-10-22 2022-05-10 株式会社Cureapp System, electronic device, method, and program for adjusting amount of medication intake
US12046341B2 (en) * 2021-10-05 2024-07-23 Bradford Rabin Methods and systems for electronically adjusting a dosing pattern of a patient undergoing a medical regimen

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062212A2 (en) * 2001-02-08 2002-08-15 Inverness Medical Limited A personal condition management system
US20070179347A1 (en) * 2004-03-15 2007-08-02 Lionel Tarassenko Medical data display

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5956501A (en) * 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
US20010037217A1 (en) * 2000-03-21 2001-11-01 Daniel Abensour Method to determine insulin dosage requirements via a diabetic management internet web site which is also telephony accessible including extensions to general diet management
US20050038674A1 (en) * 2003-04-15 2005-02-17 Braig James R. System and method for managing a chronic medical condition
US8909330B2 (en) * 2009-05-20 2014-12-09 Sotera Wireless, Inc. Body-worn device and associated system for alarms/alerts based on vital signs and motion

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062212A2 (en) * 2001-02-08 2002-08-15 Inverness Medical Limited A personal condition management system
US20070179347A1 (en) * 2004-03-15 2007-08-02 Lionel Tarassenko Medical data display

Also Published As

Publication number Publication date
GB0721117D0 (en) 2007-12-05
JP2011501311A (en) 2011-01-06
EP2215574A2 (en) 2010-08-11
AU2008315720A1 (en) 2009-04-30
WO2009053713A2 (en) 2009-04-30
US20100312580A1 (en) 2010-12-09

Similar Documents

Publication Publication Date Title
WO2009053713A3 (en) System for assisting in drug dose optimisation
Gammaitoni et al. Clinical application of opioid equianalgesic data
Kulkarni et al. Consensus statement on anaesthesia for day care surgeries
Borrás-Blasco et al. Acceptability of switching adalimumab from a prefilled syringe to an autoinjection pen
WO2005103687A3 (en) System and method for providing optimal concentrations for medication infusions
Lin et al. Use of dexmedetomidine for sedation in critically ill mechanically ventilated pediatric burn patients
Dotson Daily interruption of sedation in patients treated with mechanical ventilation
EP2392363A3 (en) Drug coated expandable devices
DE602006014934D1 (en) MANAGEMENT OF PUBLISHING ORDINARY MEDICINAL PRODUCTS
Miner et al. Sufentanil sublingual tablet 30 mcg for moderate-to-severe acute pain in the ED
Gilardi et al. PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD
Myers et al. Addressing the potential for perioperative relapse in those recovering from opioid use disorder
Raeder Opioids in the treatment of postoperative pain: old drugs with new options?
GB2458614A (en) Method and system for remotely administering a diuretic therapy
Cope Cancer pain management considerations in older adults
Peragallo-Dittko Removing barriers to insulin therapy
Quenqua Rethinking addiction’s roots, and its treatment
Babazade et al. Sufentanil sublingual tablet system for the management of postoperative pain
Dogra et al. Tacrolimus for treatment of toxic epidermal necrolysis
Ilias et al. Optimizing pain control through the use of implantable pumps
Hoya et al. Evaluation of analgesic effect and safety of fentanyl transdermal patch for cancer pain as the first line
Gregg et al. Treatment of psychiatric disorders in chronic kidney disease patients
Shaghouli et al. The prescription of insulin pen devices versus syringes for older people with diabetes
Weiner et al. A first-in-humans phase I cancer clinical trial for 4-Demthyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN).
Bloomberg Medications to help quit smoking

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2008840912

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008315720

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2010530547

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2008315720

Country of ref document: AU

Date of ref document: 20081027

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12734332

Country of ref document: US